SANDOSTATIN

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, Hong Kong, Croatia, Ireland, Japan, Lithuania, Malta, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug SANDOSTATIN contains one active pharmaceutical ingredient (API):

1 Octreotide UNII 75R0U2568I - OCTREOTIDE ACETATE

Octreotide is a synthetic octapeptide derivative of naturally occurring somatostatin with similar pharmacological effects, but with a considerably prolonged duration of action. It inhibits pathologically increased secretion of growth hormone (GH) and of peptides and serotonin produced within the GEP endocrine system. Read about Octreotide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SANDOSTATIN Solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H01CB02	Octreotide	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01C Hypothalamic hormones → H01CB Somatostatin and analogues
Discover more medicines within H01CB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 6227R, 6228T, 6229W, 9508K, 9509L, 9510M
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 526513701155411, 526513702151411, 526513703158418, 526514110079603, 526514110079703, 526514110079803, 526527204159311, 526527206151318
Country: CA	Health Products and Food Branch	Identifier(s): 00839191, 00839205, 02049392, 02239323, 02239324, 02239325
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 17.775-2-09-03, 22.530-1-05-06, 348-MEE-0614
Country: EE	Ravimiamet	Identifier(s): 1004926, 1875292, 1875304, 1875315, 1875326, 1875337, 1875348
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 59559, 59561, 62139, 62140, 62141
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 057349, 057455, 379669, 379677, 379685, 442699
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 146702, 146710, 162403, 38124, 38776, 40676
Country: HK	Department of Health Drug Office	Identifier(s): 32470, 32471, 33912, 44139, 44140, 44141
Country: IE	Health Products Regulatory Authority	Identifier(s): 88175, 88176, 88177
Country: JP	医薬品医療機器総合機構	Identifier(s): 2499403A1037, 2499403A2033
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1007829
Country: MT	Medicines Authority	Identifier(s): MA1249/00601
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 5148, 5149, 5150, 5151, 5152, 5153
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100059987, 100059993, 100091258, 100091264, 100091270
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W59079001
Country: SG	Health Sciences Authority	Identifier(s): 03808P, 03809P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699504750508
Country: US	FDA, National Drug Code	Identifier(s): 0078-0180, 0078-0181, 0078-0182
Country: ZA	Health Products Regulatory Authority	Identifier(s): V/34/0232